{"id":742994,"date":"2023-03-28T07:04:19","date_gmt":"2023-03-28T11:04:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/"},"modified":"2023-03-28T07:04:19","modified_gmt":"2023-03-28T11:04:19","slug":"freeline-therapeutics-to-host-full-year-2022-financial-results-call","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/","title":{"rendered":"Freeline Therapeutics to Host Full Year 2022 Financial Results Call"},"content":{"rendered":"<div class=\"mw_release\">\n<p>LONDON, March  28, 2023  (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc\u00a0(Nasdaq: FRLN) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, April 4, 2023 to report its full year 2022 financial results and provide a corporate update.<\/p>\n<p>To access the conference call, participants may register <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v_1BbYuxInSl9MBEMqf3kAXMda7JToVdLs2e65kdCeoouUA4WD_1tpQUqjW5OF5HoXMzxaemN3x97mcH1-p6JEIYPy40lzzNK7RN2VHGpn1Y-LhPNq8FGQO3jx7r6oxbtufe1uWQk-RLHHyNkkNMAg==\" rel=\"nofollow noopener\" target=\"_blank\">here<\/a>. While not required, it is recommended that participants join the call 10 minutes prior to the scheduled start. A live webcast of the call will also be available on the Investors section of Freeline\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CpZoaEQE0EahyHEy2Ph2tkJJ4_msWsZkfQxpjEKVnVktuiWQspVB-SHtsr2_Iz4inTeKP3S07qcqVJ8m9yFnYA==\" rel=\"nofollow noopener\" target=\"_blank\">www.freeline.life<\/a>. An archived replay of the webcast be available for approximately 90 days following the call.<\/p>\n<p>\n        <strong>About Freeline Therapeutics<\/strong><br \/>\n        <br \/>Freeline is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies. The company is dedicated to improving patient lives through innovative, one-time treatments for chronic debilitating diseases. Freeline uses its proprietary, rationally designed AAV vector and capsid (AAVS3), along with novel promoters and transgenes, to deliver a functional copy of a therapeutic gene into human liver cells, thereby expressing a persistent functional level of the missing or dysfunctional protein into the patient\u2019s bloodstream. The company is advancing clinical programs in Fabry disease and Gaucher disease Type 1. Freeline is headquartered in the UK and has operations in the United States. For more information about the company, visit www.freeline.life or connect with Freeline on LinkedIn and Twitter.<\/p>\n<p>\n        <strong>Media and Investor Contact:<\/strong><br \/>\n        <br \/>Naomi Aoki<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JhGu8iGuM1ewfxnVYlVzwmLQw9ADHpRJqc_KoBR6aehSqhS_dxXQUbwfkdFOZT577ivlCOqNfDTS-w43EYZvXrKgpgPQUv1zKMTmO0pKxs-_D_ob3w9uWM_d73qlb6YVorsfIy_aUqCrRAg1nP3GLSDwoZ7_ov0LeYaXDNqj_SOgZERO0XtAEtu7r--OMp3g_iUbYlY_K2f9Ftei2mStTwptGvpmB1WTjavscReq-jByMmjO08DQKhgaBteSCd_5dkz9AzyUVdCOqsYId1Cxqw==\" rel=\"nofollow noopener\" target=\"_blank\">naomi.aoki@freeline.life<\/a><br \/>Senior Vice President, Head of Investor Relations &amp; Communications<br \/>+ 1 617 283 4298<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NjIyNiM1NDkzODY4IzIyMDAzNjk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YTk2MjZlMmUtMDM2YS00NWI2LWJkMzUtOWFkYWM2NTY2ODM1LTEyMTE5MjI=\/tiny\/Freeline-Therapeutics-Holdings.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LONDON, March 28, 2023 (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc\u00a0(Nasdaq: FRLN) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, April 4, 2023 to report its full year 2022 financial results and provide a corporate update. To access the conference call, participants may register here. While not required, it is recommended that participants join the call 10 minutes prior to the scheduled start. A live webcast of the call will also be available on the Investors section of Freeline\u2019s website at www.freeline.life. An archived replay of the webcast be available for approximately 90 days following the call. About Freeline Therapeutics Freeline is a clinical-stage biotechnology company developing transformative adeno-associated virus &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Freeline Therapeutics to Host Full Year 2022 Financial Results Call&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-742994","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Freeline Therapeutics to Host Full Year 2022 Financial Results Call - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Freeline Therapeutics to Host Full Year 2022 Financial Results Call - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LONDON, March 28, 2023 (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc\u00a0(Nasdaq: FRLN) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, April 4, 2023 to report its full year 2022 financial results and provide a corporate update. To access the conference call, participants may register here. While not required, it is recommended that participants join the call 10 minutes prior to the scheduled start. A live webcast of the call will also be available on the Investors section of Freeline\u2019s website at www.freeline.life. An archived replay of the webcast be available for approximately 90 days following the call. About Freeline Therapeutics Freeline is a clinical-stage biotechnology company developing transformative adeno-associated virus &hellip; Continue reading &quot;Freeline Therapeutics to Host Full Year 2022 Financial Results Call&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-28T11:04:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NjIyNiM1NDkzODY4IzIyMDAzNjk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Freeline Therapeutics to Host Full Year 2022 Financial Results Call\",\"datePublished\":\"2023-03-28T11:04:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/\"},\"wordCount\":256,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NjIyNiM1NDkzODY4IzIyMDAzNjk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/\",\"name\":\"Freeline Therapeutics to Host Full Year 2022 Financial Results Call - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NjIyNiM1NDkzODY4IzIyMDAzNjk=\",\"datePublished\":\"2023-03-28T11:04:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NjIyNiM1NDkzODY4IzIyMDAzNjk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5NjIyNiM1NDkzODY4IzIyMDAzNjk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Freeline Therapeutics to Host Full Year 2022 Financial Results Call\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Freeline Therapeutics to Host Full Year 2022 Financial Results Call - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/","og_locale":"en_US","og_type":"article","og_title":"Freeline Therapeutics to Host Full Year 2022 Financial Results Call - Market Newsdesk","og_description":"LONDON, March 28, 2023 (GLOBE NEWSWIRE) &#8212; Freeline Therapeutics Holdings plc\u00a0(Nasdaq: FRLN) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, April 4, 2023 to report its full year 2022 financial results and provide a corporate update. To access the conference call, participants may register here. While not required, it is recommended that participants join the call 10 minutes prior to the scheduled start. A live webcast of the call will also be available on the Investors section of Freeline\u2019s website at www.freeline.life. An archived replay of the webcast be available for approximately 90 days following the call. About Freeline Therapeutics Freeline is a clinical-stage biotechnology company developing transformative adeno-associated virus &hellip; Continue reading \"Freeline Therapeutics to Host Full Year 2022 Financial Results Call\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-28T11:04:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NjIyNiM1NDkzODY4IzIyMDAzNjk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Freeline Therapeutics to Host Full Year 2022 Financial Results Call","datePublished":"2023-03-28T11:04:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/"},"wordCount":256,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NjIyNiM1NDkzODY4IzIyMDAzNjk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/","name":"Freeline Therapeutics to Host Full Year 2022 Financial Results Call - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NjIyNiM1NDkzODY4IzIyMDAzNjk=","datePublished":"2023-03-28T11:04:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NjIyNiM1NDkzODY4IzIyMDAzNjk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5NjIyNiM1NDkzODY4IzIyMDAzNjk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/freeline-therapeutics-to-host-full-year-2022-financial-results-call\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Freeline Therapeutics to Host Full Year 2022 Financial Results Call"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742994","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=742994"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/742994\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=742994"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=742994"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=742994"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}